glp 1 rash GLP-1 medications are changing more than weight management — they may also impact certain inflammatory skin conditions. Curious how these treatments connect to skin health? Read our latest blog to learn what Hypersensitivity to glucagon‐like peptide‐1 receptor

Private hospital networks and specialty clinics are establishing structured weight management programs incorporating pharmacotherapy alongside lifestyle interventions

[DOI] [PubMed] [Google Scholar] 270.Cambi M.P.C., Baretta G.A.P., Magro D.O., Boguszewski C.L., Ribeiro I.B., Jirapinyo P., de Moura D.T.H

As the wealth of research continues to evolve, ongoing and future trials will help refine the role of GLP-1 RAs in a broader range of conditions and chart new therapies for the next generation of cardiovascular care

10.1016/j.ecl.2020.10.002 Endocrinol Metab Clin North Am

Anti-Apoptotic and Anti-Oxidative Effects The drugs activate anti-apoptotic proteins and block pro-apoptotic pathways to protect cardiomyocytes against ischemia and oxidative stress [30]

Retatrutide, also known as "Reta," is a next-generation GLP-1 medication being developed by Eli Lilly to treat obesity